Brachytherapy Seed Manufacturers Rally For Discrete OPPS Payment Codes
This article was originally published in The Gray Sheet
Executive Summary
Medicare should accommodate the variability in prices of radioactive sources when transitioning brachytherapy "pass-through" device costs into the ambulatory payment classification (APC) pool, industry reps testified April 5 at CMS' Baltimore "town hall" meeting on the OPPS update for 2003
You may also be interested in...
Multiple Procedure Discount Will Not Apply To APC 225 – OPPS Final Rule
The status indicator for APC 225 (implantation of neurostimulator electrodes) will be changed to "S" for significant procedure, preventing it from receiving a multiple procedure discount, according to the 2003 hospital outpatient prospective payment system final rule
Multiple Procedure Discount Will Not Apply To APC 225 – OPPS Final Rule
The status indicator for APC 225 (implantation of neurostimulator electrodes) will be changed to "S" for significant procedure, preventing it from receiving a multiple procedure discount, according to the 2003 hospital outpatient prospective payment system final rule
Prostate Brachytherapy $5,381 Payment Rate Inadequate – Stakeholders
CMS will need to determine whether the two isotopes used in prostate brachytherapy are cost equivalent before the agency publishes its 2003 hospital outpatient prospective payment system (OPPS) final rule on Nov. 1